Coincidence Or Conspiracy?
It's all in an 'e' or is it an 'a'?
Read this short post with a large pinch of salt and a smile of disbelief. Shut-off the nagging whisper in the back of your head born out of the number of times in the last 3 years when one’s thinking, officially labeled by the NPCs and fact-chuckers of the technofascista as ‘conspiratorial’ or ‘disinformation’, or became canon fodder for the ‘Disinformation Project’, subsequently materialised into reality.
Just keep in mind, as I have mentioned before,
‘The Access to COVID-19 Tools Accelerator plans more than 15 billion doses of COVID-19 vaccines by 2026’.
‘The “Accelerator” is a collaboration created in April by global health and private sector organizations including the Bill & Melinda Gates Foundation, the Wellcome Trust and WHO, the Coalition for Epidemic Preparedness Innovation (CEPI), and Gavi, the Vaccine Alliance...’
You may ‘safely’ conclude, based on the merit of the size of the ‘investment’, that the assault on humanity is not about to cease anytime soon. The investment is colossal.
So, in contemplating the incremental end of the world as you know it, you may care to distract yourself and enjoy some levity with a twist. Please keep in mind the following word: parapraxis (Freudian Slip) that is described to mean (in psychoanalysis),
Revealing an unconscious [or repressed] desire or conflict through a mistake, for example, a slip of the tongue or forgetting someone’s name.
The intent here is not to debate or analyze the validity of the concept of parapraxis (it appears to possess some) but to smile or wince at the one seemingly on display here.
But let’s first start with this, just out.
The Kaufman Institute for Coincidence is a wonderfully sardonic video in a similar vein to the humour displayed in, MinusIQ | The pill to lower your IQ permanently, although in the instance of the Kaufman Institute, the observed truth has the insistence of a room full of rattlers.
The Kaufman Institute for Coincidence
Are you or a loved one suffering from a medical coincidence? You want proper medical care, but you don’t want people sniffing around asking a whole bunch of questions about what might be causing your problem. At the Kaufman Institute for Coincidence we won’t look into the cause of your heart or other problem, we’ll just fix it. That’s right, we promise to only look at your symptoms. We won’t get all curious looking for causes, because that could get your employer, or your doctor, into some legal hot water. And nobody wants that! At Kaufman, we understand that coincidence is now the leading cause of death. And if we want to operate at the speed of science, there’s no time for looking for causes. That’s right, no pesky questions about drugs or vaccines you might have been given. At Kaufman, we specialize in the effects and leave the causes to the conspiracy theorists. And let’s be honest, we know the cause anyway. It was a coincidence, right? For each new patient, Kaufman’s talented team of doctors strap on their blinders and look directly at the problem area, usually the heart, just like the CDC recommends.
Our main campus now treats the following coincidences:
-myocarditis
-blood clots
-heart arrhythmia
-stroke
-heart attack
-magnetic skin
-difficulty breathing
-full body blisters and burning
-convulsions
-kidney failure
-memory loss
-cancer
-sudden death
-and much much moreGive your coincidence the attention it deserves, but not the wrong kind of attention, at Kaufman. Schedule your appointment today at KaufmanCoincidence.com and receive a doctor’s note with real sciency sounding explanation to provide to your anti-vax friends, proving to them it was definitely not the vaccine that caused your coincidence. Kaufman: Because coincidences happen… pretty much all the time.
Official Medical Coincidence partner of the NFL.
Now To Hollyweird
Do you remember this?
Or perhaps this?
Yes, it is arguably Hollyweird at its struggling best, with Fleming’s fictional 007 James Bond reliably saving the World from SPECTRE.
SPECTRE seems a fairly accurate representation of evil criminality, hubris and psychopathy, definitely not out to save the World but to subjugate it.
‘The “Accelerator” is a collaboration created in April by global health and private sector organizations including the Bill & Melinda Gates Foundation, the Wellcome Trust and WHO, the Coalition for Epidemic Preparedness Innovation (CEPI), and Gavi, the Vaccine Alliance...’
….and the WEF is tentacled in there, albeit not quite the visible centre-piece.
The Sign Of The Beast ~ SPECTRE
SPECTRE (an acronym of Special Executive for Counter-intelligence, Terrorism, Revenge, and Extortion) is a vast international organisation with its own elaborate facilities. The top-level members of 21 individuals, 18 of whom handled day-to-day affairs and were drawn in groups of three from six of the world's greatest criminal organisations. SPECTRE's main strategy was to instigate conflict between powerful enemies hoping that they would exhaust themselves and be vulnerable when it seizes power. SPECTRE thus works with all sides in a war.
"SPECTRE is a dedicated fraternity whose strength lies in the absolute integrity of its members."
Now, let’s turn back to the dystopian nightmare that we accept for the moment as reality, where the tangled tentacles of BigPharma, BigGOV, WEF, WHO, that spidery (forgive the mixed metaphor) global corporate conglomerate currently doing all it can to position the WHO to quite literally take over the World through the current secret machinations of its International Health Rules Review Committee.
Conspiracy? ‘Yeah, Right’.
SECRET NEGOTIATIONS FOR THE AMENDMENTS TO THE INTERNATIONAL HEALTH REGULATIONS
Now Pause For Thought
There is a Chinese company determined to get a decent slice of the 15 billion shot action named,
The key DAVOS cloned orchestrator remains,
They’re deadly serious. They schedule 15 billion COVID injections by 2026 with no intention of ceasing anytime soon, unless they are physically stopped. Clover BioPharma wants a decent slice of the action so they’ve come up with a novel jab, recombining an old and inadequte adjuvant (a substance in an injection that is said to provoke a more robust reaction of immune response) with a modern adjuvant. They aim to produce 400 million shots to start.
In 2021, CEPI announced with pride the consequences of their sponsoring development with the following:
Clover Biopharmaceuticals’ COVID-19 vaccine candidate (SCB-2019) is the latest to join the growing COVAX portfolio of vaccines.
It follows in the footsteps of the CEPI-supported Oxford/AstraZeneca, Moderna, and Novavax COVID-19 vaccine programmes – of which contribute, or are set to contribute, hundreds of millions of doses of their candidates to our scheme to protect priority populations worldwide.
Through an agreement signed by COVAX co-lead, Gavi, Clover is set to make over 400 million doses of its vaccine candidate available for procurement in 2021 and 2022, pending Emergency Use Listing (EUL) from the World Health Organization (WHO). An initial 64 million doses of this vaccine are expected to be available by the end of 2021. The candidate could also be one of the first protein-based COVID-19 vaccines to be distributed through the global mechanism.
By investing early in the promising vaccine technology, and ‘baking in’ access commitments into our contracts, CEPI has been able to catalyse the development of and equitable access to Clover’s vaccine candidate.
Clover Biopharmaceuticals did not make the rapid progress anticipated by CEPI and stated in their Update on 2022 Corporate Milestones:
Significant progress made on regulatory submissions to the China NMPA, the EMA, and the WHO for Clover’s lead COVID-19 vaccine candidate, SCB-2019 (CpG 1018/Alum), with completion anticipated in Q4 2022.
The company squeezed in at the end of 2022 and now state in their COVID-19 Vaccine Technology article:
In December 2022, we received emergency use authorization for SCB-2019 (CpG 1018/Alum) in the People’s Republic of China. In addition, we are pursuing regulatory approval of SCB-2019 (CpG 1018/Alum) with the European Medicines Agency and the World Health Organization. We are also pursuing regulatory submissions and potential bilateral supply agreements strategically in certain countries.
Leveraging Trimer-Tag™ technology platform, we developed the SCB-2019 antigen and combined it with Dynavax’s CpG 1018 advanced adjuvant and aluminum hydroxide (alum), to create our protein-based COVID-19 vaccine candidate.
SCB-2019 (CpG 1018/Alum), our COVID-19 vaccine candidate, is a recombinant SARS-CoV-2 fusion protein that preserves the native trimeric structure of the S-protein in the prefusion conformation form, which is important for eliciting protective immunity against the SARS-CoV-2 virus.
[This S-protein is added to two adjuvants]
Constituents
And what of the constituents: here’s a head’s up about the adjuvants.
Thee use of an aluminium adjuvant ‘Alum’ that is stated by the US CDC to be potassium aluminum sulfate, although Clover Bipharma oddly state it is aluminum hydroxide. Respected standard sources confirm ‘alum’ as a double sulfate salt of potassium and aluminum.
Of CpG1018, the US CDC states that CpG 1018 (whose generic name is IS-1018), …
… is a recently developed adjuvant used in Heplisav-B vaccine made up of cytosine phosphoguanine (CpG) motifs, which is a synthetic form of DNA that mimics bacterial and viral genetic material. When CpG 1018 is included in a vaccine, it increases the body’s immune response.
In pre-licensure clinical trials, adverse events after Heplisav-B were comparable to those observed after another U.S.-licensed, non-adjuvanted hepatitis B vaccine.
Development of the CpG Adjuvant 1018: A Case Study
The development of aluminum salts (alum) as vaccine adjuvants was an empirical process with little understanding of the mechanism of action and, with decades of use, it has become clear that there is a need for alternatives where alum-based adjuvants are suboptimal. Oligonucleotides containing unmethylated CpG sequences represent one alternative as they are potent stimulators of the vertebrate innate immune system through activation of Toll-like receptor-9.
1018 is a short (22-mer) oligonucleotide sequence containing CpG motifs active in both rodents and primates. Preclinical testing of hepatitis B surface antigen (HBsAg) + 1018 in comparison to HBsAg + alum demonstrated induction of substantially higher antibody titers and a favorable safety profile for 1018.
HBsAg + 1018 (HEPLISAV-B™) is currently [2017] in late-stage clinical testing for prophylactic immunization against HBV.
Okay, now let’s return to our star company for the finale…
Well done for reaching this far.
Our COVID-19 vaccine: SCB-2019 (CpG 1018/Alum)
The phase 1 clinical trial was reported in the Lancet, ‘Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial’
As part of the accelerated development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we report a dose-finding and adjuvant justification study of SCB-2019, a protein subunit vaccine candidate containing a stabilised trimeric form of the spike (S)-protein (S-Trimer) combined with two different adjuvants.
Quite the novel brew. Now the punch line.
In September 2021, we announced that SPECTRA, a global pivotal Phase 2/3 clinical trial evaluating the efficacy, safety, and immunogenicity of SCB-2019 (CpG 1018/Alum) met the primary and secondary efficacy endpoints.
Quite the novel name for a global trial, or just a pesky parapraxis?
In December 2022, we received emergency use authorization for SCB-2019 (CpG 1018/Alum) in the People’s Republic of China. In addition, we are pursuing regulatory approval of SCB-2019 (CpG 1018/Alum) with the European Medicines Agency and the World Health Organization. We are also pursuing regulatory submissions and potential bilateral supply agreements strategically in certain countries.
Post Script
Truth is stranger than fiction, coincidence is just conspiracy.
Remember the line in the 007 movie of 2015 where SPECTRE was described as "everywhere"? That line and the "squid" motif of the 007 movie clearly hearkens back to journalist Matt Taibbi's famous description of Goldman Sachs in his 2010 RollingStone article:
"The first thing you need to know about Goldman Sachs is that it’s everywhere. The world’s most powerful investment bank is a great vampire squid wrapped around the face of humanity, relentlessly jamming its blood funnel into anything that smells like money."
As we all know now, ever since Taibbi's article came out, GS is referred to relentlessly as "the Vampire Squid" or simply "the Squid". The cabal loves to taunt us by reminding us peons, via referential symbolism, of their power.